Products

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.

See all 1 product →

About Cardiomatics

Cardiomatics is a healthcare AI company that has developed a cloud-based, medical-grade software for the analysis of ambulatory (Holter) ECG tests. The platform utilizes clinically validated AI algorithms to provide accurate and high-quality results, aiming to transform how healthcare professionals conduct ECG analysis. Their system is designed to automate the detection and analysis of various heart abnormalities and disorders, generating comprehensive reports in minutes, which is significantly faster than traditional manual interpretation.

For physicians, Cardiomatics offers a tool to enhance efficiency and precision in cardiac diagnostics. The software provides comprehensive analysis reports in an interactive and user-friendly web application, detailing a wide range of anomalies. It is compatible with over 60 Holter ECG devices and can integrate with hospital systems, making it a flexible solution for cardiac clinics, general practitioners, and partners. By reducing the time spent on analysis, Cardiomatics allows medical professionals to optimize their workflow, see more patients, and improve early detection and referral for cardiac conditions. The company’s algorithms have been trained on millions of hours of ECG data, ensuring precise and consistent results, and the platform is CE-marked and MDR-certified, signifying its adherence to European medical device regulations.

Focus Areas

AI-powered ECG analysis Holter ECG interpretation cardiac diagnostics arrhythmia detection cloud-based medical software

Business Intelligence

Key InvestorsKaya VC, Nina Capital, Innovation Nest, Nova Capital (Italy), INNOventure, Polish National Centre of Research and Development, RTA Ventures
PartnershipsBIOTRONIK, Arseus Medical, University Hospital Basel
TechnologyCloud-based, AI algorithms, interoperable with over 60 Holter ECG devices

What Physicians Need to Know

Specialization: AI-powered ECG Analysis
Cardiomatics specializes in AI-powered analysis of ambulatory (Holter) ECG tests, automating the interpretation process. Their algorithms have been trained on over 8 million hours of Holter ECG data, ensuring precise and consistent results.
Specialization: Arrhythmia Detection
The platform offers comprehensive detection of over 20 significant anomalies, including Atrial Fibrillation (AFib)/Flutter, SVT, VT, pauses, and AV blocks.
Specialization: Cloud-based Medical Software
Cardiomatics is a fully cloud-based solution, accessible from any device with an internet connection and no installation required.
Key Differentiator: Time-Saving for Physicians
The AI-based analysis can cut Holter ECG interpretation time by up to 80%, saving cardiologists up to 2.5 hours per Holter ECG, especially in cases with multiple AF episodes.
Key Differentiator: Accuracy and Clinical Validation
Cardiomatics demonstrates a 99.8% correlation in AF detection compared to manual physician assessment and is a certified Class IIa medical device with EU-MDR certification.
Key Differentiator: Increased Efficiency and Volume
The system enables an 68% increase in Holter ECG volume and allows for the automated analysis of long recordings (77% of signals are 7 days or longer).
Technology Stack: AI Algorithms
Their core technology relies on machine learning algorithms trained on extensive Holter ECG data to provide accurate and reliable interpretations.
Technology Stack: Cloud Infrastructure
Cardiomatics utilizes a secure and compliant cloud infrastructure with 81 international security certificates, including ISO 27000 and ISO 27001, ensuring data encryption and adherence to medical data protection standards.
Technology Stack: Interoperability
The platform is compatible with over 60 Holter ECG devices and is designed for integration with hospital systems.
Physician Tip

For physicians, Cardiomatics offers a significant reduction in the time spent on Holter ECG analysis, allowing more time for patient interaction and clinical decision-making. The high accuracy and clinical validation of its AI algorithms provide reliable results, supporting precise cardiac diagnostics and early detection of arrhythmias. Its cloud-based nature means no software installation is needed, offering immediate access from any device with internet, streamlining workflow for cardiac clinics, GPs, and hospitals. The platform's ability to analyze long-term ECG recordings automatically helps manage increased patient volumes and reduce diagnostic waiting times.

Cardiomatics is compatible with over 60 Holter ECG devices and is ready to integrate with various hospital systems. They also offer flexible integration options for connecting with other clinical applications and reporting tools. Partnerships, such as with Biotronik in Germany, further expand their reach and integration capabilities with advanced ECG-Patch Holter Monitors.

Products by Cardiomatics

1 product in the directory

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.

What the Web Says

Cardiomatics is an AI-powered, cloud-based platform for ECG analysis, aiming to significantly reduce the time cardiologists spend on Holter interpretation and improve diagnostic efficiency. The software is designed to be user-friendly, accurate, and compatible with a wide range of ECG devices. It has been clinically validated in studies, demonstrating high precision in detecting conditions like atrial fibrillation.

Overall: Positive

Strengths

  • Reduces Holter interpretation time by up to 80%.
  • High accuracy and reliability in ECG analysis, with 99.8% correlation in AF detection.
  • User-friendly and intuitive web-based platform.
  • Compatible with over 60 Holter ECG devices.
  • Enables clinics to analyze more patients without increasing staff or equipment.
  • Provides comprehensive and easy-to-read reports.

Limitations

  • No specific cons were found in the provided search results from G2, Glassdoor, Capterra, or Reddit regarding Cardiomatics' product or employer reviews.
  • General challenges with patient engagement software include adoption, integrations, and compliance.

Based on reviews from: Diagnostic and Interventional Cardiology, Arseus Medical, Cardiomatics AI, Cardiomatics, YouTube

Last updated: 2026-08-24

Videos

News, demos, and interviews about Cardiomatics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Cardiomatics →

View all on YouTube

Press & Coverage

Cardiomatics News
Arseus Medical and Cardiomatics bring AI-powered Holter ECG analysis to Clinique Saint-Luc Bouge
Cardiomatics partnered with Arseus Medical to provide AI-powered Holter ECG analysis to Clinique Saint-Luc Bouge in Belgium, enhancing cardiac diagnostics with a modern and efficient approach. This collaboration aims to support ambulatory ECG interpretation in the region.
2026-06
Diagnostic and Interventional Cardiology
Cardiomatics Cooperates with the Biotronik Sales Organization in Germany to Accelerate the Growth of its Leading AI-powered ECG Analysis Solution in the German Market
Cardiomatics and Biotronik's German sales organization have partnered to accelerate the adoption of AI in early detection and management of cardiac events. Biotronik will distribute Cardiomatics' AI-powered ECG analysis solution alongside its net_ECG advanced ECG-Patch Holter Monitor in Germany.
2024-06
Diagnostic and Interventional Cardiology
Cardiomatics Obtains the World's 1st MDR Certification for AI-based ECG Interpretation and Implements new Functionalities
Cardiomatics achieved the world's first MDR certification for AI-based ECG interpretation software and introduced new functionalities, including Atrioventricular block detection of 2nd and 3rd degrees. This certification ensures the solution's quality, safety, and reliability in compliance with EU regulations.
2023-10
Diagnostic and Interventional Cardiology
Clinical Study Shows Cardiomatics AI Technology is Accurate Tool for Assessment of Atrial Fibrillation
A study conducted by the University Hospital Basel validated Cardiomatics' AI technology as an accurate and efficient tool for assessing atrial fibrillation burden from 7-day Holter-ECG recordings. The software significantly reduced analysis time compared to manual methods while maintaining high-quality data.
2023-02
Cardiomatics News
How AI-Powered Holter ECG Analysis is Advancing Cardiometabolic Research
Cardiomatics collaborated with University Hospital Basel on a study published in Diabetes Care, exploring how metformin can protect against the harmful effects of glucocorticoids. The research utilized AI-powered ECG analysis to measure heart rate variability, contributing valuable data for future cardiometabolic research.
2025-02
Cardiomatics (via Google Search)
Cardiomatics raises $3.2 million in seed funding
Cardiomatics secured $3.2 million in seed funding, led by KAYA VC, with participation from Nina Capital, Innovation Nest, and Nova Capital. The funding will be used for product development, expanding business activities, and preparing for new market launches.
2021-08

Frequently Asked Questions

Cardiomatics is a cloud-based AI platform designed for automated ECG analysis, particularly for Holter ECGs. It helps physicians and healthcare administrators by providing rapid, accurate, and consistent interpretations of ECG data, aiming to improve the efficiency of cardiac diagnostics and arrhythmia detection.
Cardiomatics' AI algorithms are developed and validated using large datasets of ECGs and are continuously refined. The system is designed to assist clinicians by flagging abnormalities and providing detailed reports, which are then reviewed and finalized by medical professionals, ensuring a high level of accuracy and clinical utility.
Cardiomatics offers a cloud-based platform for ECG analysis, focusing on Holter monitoring. Their service streamlines the interpretation process, providing comprehensive reports that can be easily integrated into existing electronic health record (EHR) systems, aiming to enhance diagnostic workflows and reduce turnaround times.
Cardiomatics adheres to strict compliance standards for data security and patient privacy, including GDPR and HIPAA regulations. The platform is also certified as a medical device, ensuring it meets the necessary regulatory requirements for safety and performance in clinical settings.
Cardiomatics typically offers flexible pricing models, often based on usage or subscription tiers, to accommodate different practice sizes and needs. They provide comprehensive technical support and training for healthcare professionals to ensure seamless integration and effective utilization of their platform.
Cardiomatics is a growing company with a strong focus on advancing AI in cardiac diagnostics. They are continuously investing in research and development to expand their capabilities, improve algorithm accuracy, and explore new applications within the field of cardiology.

Investors

Who's funded Cardiomatics.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.